Agilent and C-CAMP expand biopharma analytics access across India for cheaper faster drug research

Shared mass spectrometry access without buying instruments

Agilent Technologies has expanded its collaboration with C-CAMP to broaden India’s access to advanced, high-resolution analytical and mass spectrometry platforms. The shared-infrastructure model lets startups, academia, and industry use specialized workflows for tasks like biotherapeutic characterization and quantitative biomolecular analysis—reducing the need for large upfront capital investments while supporting more reproducible translational research.